Charles Schwab
BPTH

Charles Schwab’s Bio-Path Holdings Inc BPTH Stock Holding History

Charles Schwab’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-33
Closed -$109K – 3149
2017
Q1 		$109K Hold
33
– – ﹤0.01% 3006
2016
Q4 		$178K Hold
33
– – ﹤0.01% 2986
2016
Q3 		$184K Hold
33
– – ﹤0.01% 2934
2016
Q2 		$262K Buy
+33
New +$334K ﹤0.01% 2831
2015
Q2 		– Sell
-27
Closed -$194K – 3134
2015
Q1 		$194K Hold
27
– – ﹤0.01% 2953
2014
Q4 		$287K Hold
27
– – ﹤0.01% 2859
2014
Q3 		$217K Hold
27
– – ﹤0.01% 2919
2014
Q2 		$329K Buy
+27
New +$296K ﹤0.01% 2817

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCA
Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Charles Schwab's BPTH Position: Q2 2017 in Review

Charles Schwab sold out of Bio-Path Holdings Inc (BPTH) in Q2 2017, closing a stake of 33 shares — an estimated $109K sold.

Charles Schwab first reported a position in BPTH in Q2 2014 and held it in 8 quarters. The position peaked at $329K in Q2 2014. 33 funds tracked by Wall St. Rank hold BPTH as of Q2 2017.

  • Charles Schwab reported no remaining Bio-Path Holdings Inc position as of Q2 2017 after selling out during the quarter.
  • Charles Schwab sold 33 Bio-Path Holdings Inc shares in Q2 2017, an estimated $109K.
  • Charles Schwab first reported a position in Bio-Path Holdings Inc in Q2 2014 and held it in 8 quarters.
  • Charles Schwab's Bio-Path Holdings Inc position peaked at $329K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2017.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.